• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒药物识别与 CNT3 的电梯式输运运动。

Antiviral drug recognition and elevator-type transport motions of CNT3.

机构信息

Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA.

Departments of Biological Sciences, Chemistry, and Bioengineering, Lehigh University, Bethlehem, PA, USA.

出版信息

Nat Chem Biol. 2024 Sep;20(9):1144-1153. doi: 10.1038/s41589-024-01559-8. Epub 2024 Feb 28.

DOI:10.1038/s41589-024-01559-8
PMID:38418906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11625470/
Abstract

Nucleoside analogs have broad clinical utility as antiviral drugs. Key to their systemic distribution and cellular entry are human nucleoside transporters. Here, we establish that the human concentrative nucleoside transporter 3 (CNT3) interacts with antiviral drugs used in the treatment of coronavirus infections. We report high-resolution single-particle cryo-electron microscopy structures of bovine CNT3 complexed with antiviral nucleosides N-hydroxycytidine, PSI-6206, GS-441524 and ribavirin, all in inward-facing states. Notably, we found that the orally bioavailable antiviral molnupiravir arrests CNT3 in four distinct conformations, allowing us to capture cryo-electron microscopy structures of drug-loaded outward-facing and drug-loaded intermediate states. Our studies uncover the conformational trajectory of CNT3 during membrane transport of a nucleoside analog antiviral drug, yield new insights into the role of interactions between the transport and the scaffold domains in elevator-like domain movements during drug translocation, and provide insights into the design of nucleoside analog antiviral prodrugs with improved oral bioavailability.

摘要

核苷类似物作为抗病毒药物具有广泛的临床应用。它们在体内的分布和细胞进入的关键是人体核苷转运蛋白。在这里,我们确定了人类高浓度核苷转运蛋白 3(CNT3)与用于治疗冠状病毒感染的抗病毒药物相互作用。我们报告了与抗病毒核苷 N-羟基胞苷、PSI-6206、GS-441524 和利巴韦林复合的牛 CNT3 的高分辨率单颗粒冷冻电镜结构,均处于内向状态。值得注意的是,我们发现可口服生物利用的抗病毒药物莫努匹韦以四种不同的构象使 CNT3 失活,使我们能够捕获药物负载的外向构象和药物负载的中间构象的冷冻电镜结构。我们的研究揭示了核苷类似物抗病毒药物在膜转运过程中 CNT3 的构象轨迹,深入了解了在药物转运过程中,转运和支架结构域之间的相互作用在电梯样结构域运动中的作用,为设计具有改善口服生物利用度的核苷类似物抗病毒前药提供了思路。

相似文献

1
Antiviral drug recognition and elevator-type transport motions of CNT3.抗病毒药物识别与 CNT3 的电梯式输运运动。
Nat Chem Biol. 2024 Sep;20(9):1144-1153. doi: 10.1038/s41589-024-01559-8. Epub 2024 Feb 28.
2
Cryo-EM structure of the human concentrative nucleoside transporter CNT3.人源核苷转运蛋白 CNT3 的冷冻电镜结构
PLoS Biol. 2020 Aug 10;18(8):e3000790. doi: 10.1371/journal.pbio.3000790. eCollection 2020 Aug.
3
Inward- and outward-facing homology modeling of human concentrative nucleoside transporter 3 (hCNT3) predicts an elevator-type transport mechanism.采用内面向外和外面向内同源建模方法对人源核苷转运蛋白 3(hCNT3)进行预测,表明其具有电梯式转运机制。
Channels (Austin). 2018;12(1):291-298. doi: 10.1080/19336950.2018.1506665.
4
Allosteric and transport modulation of human concentrative nucleoside transporter 3 at the atomic scale.在原子尺度上对人源核苷转运蛋白 3 的变构和转运进行调节。
Phys Chem Chem Phys. 2021 Nov 17;23(44):25401-25413. doi: 10.1039/d1cp03756k.
5
Concentrative Nucleoside Transporter 3 Is Located on Microvilli of Vaginal Epithelial Cells.浓缩核苷转运体3位于阴道上皮细胞的微绒毛上。
ACS Omega. 2020 Aug 13;5(33):20882-20889. doi: 10.1021/acsomega.0c02329. eCollection 2020 Aug 25.
6
Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia coli nucleoside-H(+) cotransporter (NupC) produced in Xenopus laevis oocytes.非洲爪蟾卵母细胞中产生的重组大肠杆菌核苷-H(+)共转运蛋白(NupC)对生理核苷以及抗病毒和抗肿瘤核苷药物的转运
Mol Membr Biol. 2004 Jan-Feb;21(1):1-10. doi: 10.1080/0968768031000140836.
7
Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).人类浓缩核苷转运体3(CNT3;SLC28A3)基因变异的功能分析
Pharmacogenomics J. 2005;5(3):157-65. doi: 10.1038/sj.tpj.6500303.
8
The concentrative nucleoside transporter family, SLC28.浓缩核苷转运体家族,SLC28。
Pflugers Arch. 2004 Feb;447(5):728-34. doi: 10.1007/s00424-003-1107-y. Epub 2003 Jul 11.
9
Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).钠依赖性核苷转运体(CNT)家族研究的最新分子进展:对嘌呤和嘧啶核苷具有广泛选择性的新型人类和小鼠蛋白(hCNT3和mCNT3)的鉴定与特性分析(系统cib)
Mol Membr Biol. 2001 Jan-Mar;18(1):65-72. doi: 10.1080/09687680010026313.
10
Human Concentrative Nucleoside Transporter 3 (hCNT3, SLC28A3) Forms a Cyclic Homotrimer.人浓缩型核苷转运体3(hCNT3,SLC28A3)形成环状同源三聚体。
Biochemistry. 2017 Jul 11;56(27):3475-3483. doi: 10.1021/acs.biochem.7b00339. Epub 2017 Jun 29.

引用本文的文献

1
Uridine, a Therapeutic Nucleoside, Exacerbates Alcoholic Liver Disease via SRC Kinase Activation: A Network Toxicology and Molecular Dynamics Perspective.尿苷,一种治疗性核苷,通过SRC激酶激活加剧酒精性肝病:网络毒理学和分子动力学视角
Int J Mol Sci. 2025 Jun 7;26(12):5473. doi: 10.3390/ijms26125473.

本文引用的文献

1
Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1.疟原虫核苷转运蛋白 PfENT1 的底物识别和抑制机制的结构基础。
Nat Commun. 2023 Mar 28;14(1):1727. doi: 10.1038/s41467-023-37411-1.
2
CMM-An enhanced platform for interactive validation of metal binding sites.CMM—用于金属结合位点交互验证的增强型平台。
Protein Sci. 2023 Jan;32(1):e4525. doi: 10.1002/pro.4525.
3
CHARMM-GUI Enhanced Sampler for various collective variables and enhanced sampling methods.
用于各种整体变量和增强采样方法的 CHARMM-GUI 增强采样器。
Protein Sci. 2022 Nov;31(11):e4446. doi: 10.1002/pro.4446.
4
Methotrexate recognition by the human reduced folate carrier SLC19A1.人源二氢叶酸还原酶载体 SLC19A1 对甲氨蝶呤的识别。
Nature. 2022 Sep;609(7929):1056-1062. doi: 10.1038/s41586-022-05168-0. Epub 2022 Sep 7.
5
Preclinical Pharmacokinetics and Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment.GS-441524的临床前药代动力学及性质,一种潜在的用于治疗COVID-19的口服候选药物
Front Pharmacol. 2022 Aug 16;13:918083. doi: 10.3389/fphar.2022.918083. eCollection 2022.
6
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants.阿糖腺苷类似物前药 ATV006 具有口服生物利用度,对亲代 SARS-CoV-2 及其变体具有临床前疗效。
Sci Transl Med. 2022 Sep 7;14(661):eabm7621. doi: 10.1126/scitranslmed.abm7621.
7
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.口服瑞德西韦前药治疗可预防 SARS-CoV-2 在小鼠中的发病机制。
Sci Transl Med. 2022 May 4;14(643):eabm3410. doi: 10.1126/scitranslmed.abm3410.
8
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
9
New tools for automated cryo-EM single-particle analysis in RELION-4.0.用于 RELION-4.0 自动化冷冻电镜单颗粒分析的新工具。
Biochem J. 2021 Dec 22;478(24):4169-4185. doi: 10.1042/BCJ20210708.
10
Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19.细胞摄取和细胞内磷酸化的 GS-441524:对其抗 COVID-19 有效性的影响。
Viruses. 2021 Jul 14;13(7):1369. doi: 10.3390/v13071369.